BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20950382)

  • 1. Hypoglycaemia increases aldosterone in a dose-dependent fashion.
    Adler GK; Bonyhay I; Curren V; Waring E; Freeman R
    Diabet Med; 2010 Nov; 27(11):1250-5. PubMed ID: 20950382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
    Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.
    Snorgaard O; Lassen LH; Rosenfalck AM; Binder C
    J Intern Med; 1991 Apr; 229(4):343-50. PubMed ID: 2026987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of euglycaemic and hypoglycaemic hyperinsulinaemia on sympathetic and parasympathetic regulation of haemodynamics in healthy subjects.
    Laitinen T; Huopio H; Vauhkonen I; Camaro C; Hartikainen J; Laakso M; Niskanen L
    Clin Sci (Lond); 2003 Sep; 105(3):315-22. PubMed ID: 12773092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
    Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
    Nilsson M; Jensen N; Gejl M; Bergmann ML; Storgaard H; Zander M; Miskowiak K; Rungby J
    Diabetologia; 2019 Oct; 62(10):1948-1958. PubMed ID: 31367958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
    Fabricius TW; Verhulst CEM; Kristensen PL; Holst JJ; Tack CJ; McCrimmon RJ; Heller SR; Evans ML; de Galan BE; Pedersen-Bjergaard U;
    Acta Diabetol; 2024 May; 61(5):623-633. PubMed ID: 38376580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antecedent insulin level and pattern of induction of acute hypoglycaemia do not affect subsequent counterregulatory responses in healthy subjects.
    Moriarty KT; Simpson EJ; Mullinger RN; MacDonald IA; Tattersall RB
    Clin Sci (Lond); 1993 Nov; 85(5):543-8. PubMed ID: 8287641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antecedent hypoglycaemia does not diminish the glycaemia-increasing effect and glucoregulatory responses of a 10 s sprint in people with type 1 diabetes.
    Davey RJ; Paramalingam N; Retterath AJ; Lim EM; Davis EA; Jones TW; Fournier PA
    Diabetologia; 2014 Jun; 57(6):1111-8. PubMed ID: 24632737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects.
    George E; Harris N; Bedford C; Macdonald IA; Hardisty CA; Heller SR
    Diabetologia; 1995 Oct; 38(10):1183-90. PubMed ID: 8690170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.
    Fabricius TW; Verhulst CEM; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pieber TR; de Galan BE; Pedersen-Bjergaard U;
    Diabetologia; 2021 Apr; 64(4):727-736. PubMed ID: 33566134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
    Hövelmann U; Olsen MB; Mouritzen U; Lamers D; Kronshage B; Heise T
    Diabetes Obes Metab; 2019 Mar; 21(3):601-610. PubMed ID: 30350477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
    Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus.
    Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR
    Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes.
    Færch LH; Thorsteinsson B; Tarnow L; Holst JJ; Kjær T; Kanters J; Larroude C; Dela F; Pedersen-Bjergaard U
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1036-45. PubMed ID: 25070348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.